RankingsLogo

Illumina, Inc.

Illumina, Inc. is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.

Illumina, Inc. Is a biotechnology company specializing in the development, manufacturing, and marketing of integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serve the sequencing, genotyping and gene expression markets.

Ticker: ILMN

Humankind Value: $26.7 B

Revenue: $4.3 B

Market Cap: $17.4 B

Badge100_2024
Positive and negative impacts of companies graphic.

(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)

Illumina, Inc. is responsible for positive Humankind Value, in large part due to Medical Devices ($26.3 B), Economic Value ($830.8 M), and Medical Services ($296.0 M). Positive value from Medical Devices and Medical Services is linked to an estimate of 510,000 additional years lived by people worldwide. The Humankind Value of this company can improve with reductions in Biofuel Production (-$463.8 M) and Government Regimes (-$270.1 M). Medical Devices and Economic Value are attached to this company as a result of its direct business activities. Medical Services, Biofuel Production, and Government Regimes are mostly or entirely a result of supply-chain relationships.

How the Humankind Value Methodology Drives the Rankings

We take a quantitative, data-driven approach to estimating the economic impact that companies have on investors, customers, employees, and society at large, rolling social responsibility into a single dollar value that we use to represent what a company is contributing to humanity. As far as we can tell, we're the first ones doing it this way.

LEARN MORE ABOUT OUR RESEARCH
How Methodology Drives the Rankings